The Food and Drug Administration granted Moderna permission to increase the number of COVID-19 vaccine doses per vial from 10 to 14, the New York Times reports.
Zinc and Vitamin C fell short in a clinical trial after researchers found they made no significant difference in easing the duration of coronavirus symptoms.
Dr. Diane Calello, executive and medical director of the New Jersey Poison Center and a professor at the Rutgers New Jersey Medical School, discussed the risks that adhesives pose to hair and skin.
The medical technology company behind a molecular diagnostic test that can detect both the influenza virus and coronavirus in a little as two to three hours said it received Emergency Use Authorization from the FDA on Friday.
Some people in Massachusetts are offering rides and even money for a chance to take advantage of a state rule that allows those who accompany people age 75 and older to a coronavirus vaccination appointment to get a shot at the same time.
It's normal for viruses, including SARS-CoV-2, to mutate. But is there a limit to how much the virus can mutate and still make people sick — or can the virus just continue to evolve indefinitely?
While the coronavirus has been at the forefront of health news over the past year, fire departments nationwide face another crisis in rising cancer rates.
South Africa wants to sell or swap its first batch of the AstraZeneca COVID-19 vaccine just days after getting it — because a new study suggested it might not protect against its dominant mutation.
A coronavirus strain first detected in Los Angeles, Calif. appears to be spreading across the U.S., though scientists are still studying the variant’s degree of transmissibility and virulence.
California has identified its first cases of a worrisome coronavirus variant that was first discovered in South Africa. The variant, known as B.1.351, was confirmed in the San Francisco Bay Area, Calif. Gov. Gavin Newsom announced this week.
Los Angeles is temporarily shutting down several city vaccination sites in the coming days after it burned through its limited allocation of first doses for Moderna’s vaccine.
AstraZeneca said Thursday it expects to have a new version of its COVID-19 vaccine ready for use by this autumn as drugmakers respond to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.
The Centers for Disease Control and Prevention (CDC) on Wednesday said that those who are fully vaccinated against coronavirus and who “meet criteria” will no longer be required to quarantine following exposure to someone with COVID-19.
Given the nation’s vaccination pace, America’s leading expert on COVID-19 predicts that shots will be available to anyone in the general public by April.